A phase 1 human immunodeficiency virus vaccine trial for cross-profiling the kinetics of serum and mucosal antibody responses to CN54gp140 modulated by two homologous prime-boost vaccine regimens

A phase 1 human immunodeficiency virus vaccine trial for cross-profiling the kinetics of serum and mucosal antibody responses to CN54gp140 modulated by two homologous prime-boost vaccine regimens

A key aspect to finding an efficacious human immunodeficiency virus (HIV) vaccine is the optimization of vaccine schedules that can mediate the efficient maturation of protective immune responses. In the present study, we investigated the effect of alternate booster regimens on the immune responses...

Full description

Bibliographic Details
Main Authors: Kratochvil, S, McKay, P, Kopycinski, J, Bishop, C, Hayes, P, Muir, L, Pinder, C, Cizmeci, D, King, D, Aldon, Y, Wines, B, Hogarth, P, Chung, A, Kent, S, Held, K, Geldmacher, C, Dally, L, Santos, N, Cole, T, Gilmour, J, Fidler, S, Shattock, R
Format: Journal article
Language:English
Published: Frontiers Media 2017

Similar Items

Similar Items